| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 75,972 | 75,270 | 75,396 | 65,540 | | Cost of Revenue | 60,196 | 60,406 | 60,451 | 52,293 | | | Gross Profit | 15,776 | 14,864 | 14,945 | 13,247 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,138 | 7,113 | 7,904 | 7,314 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,638 | 7,751 | 7,042 | 5,933 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18 | 22 | 28 | 48 | | Earnings Before Interest And Taxes | 8,656 | 7,774 | 7,069 | 5,981 | | Interest Expense | 3 | 4 | 9 | 5 | | Income Before Tax | 8,653 | 7,769 | 7,060 | 5,976 | | Income Tax Expense | 3,344 | 2,971 | 2,734 | 2,316 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,308 | 4,799 | 4,327 | 3,660 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,308 | 4,799 | 4,327 | 3,660 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,308 | $4,799 | $4,327 | $3,660 |
|
0.31% Nasdaq 
0.05%
Income Statement
